153 related articles for article (PubMed ID: 10331968)
1. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome.
Levine JS; Koh JS; Subang R; Rauch J
Exp Mol Pathol; 1999 Apr; 66(1):82-98. PubMed ID: 10331968
[TBL] [Abstract][Full Text] [Related]
2. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes.
Levine JS; Subang R; Koh JS; Rauch J
J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and the antiphospholipid syndrome.
Rauch J; Subang R; D'Agnillo P; Koh JS; Levine JS
J Autoimmun; 2000 Sep; 15(2):231-5. PubMed ID: 10968916
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
5. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.
Levine JS; Koh JS
Semin Nephrol; 1999 Jan; 19(1):34-47. PubMed ID: 9952279
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner.
Price BE; Rauch J; Shia MA; Walsh MT; Lieberthal W; Gilligan HM; O'Laughlin T; Koh JS; Levine JS
J Immunol; 1996 Sep; 157(5):2201-8. PubMed ID: 8757347
[TBL] [Abstract][Full Text] [Related]
8. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.
Bas de Laat H; Derksen RH; de Groot PG
Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159
[TBL] [Abstract][Full Text] [Related]
9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
10. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
11. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
Nojima J
Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
[TBL] [Abstract][Full Text] [Related]
12. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
Pierangeli SS; Vega-Ostertag ME; González EB
Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
[TBL] [Abstract][Full Text] [Related]
13. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies.
Manfredi AA; Rovere P; Galati G; Heltai S; Bozzolo E; Soldini L; Davoust J; Balestrieri G; Tincani A; Sabbadini MG
Arthritis Rheum; 1998 Feb; 41(2):205-14. PubMed ID: 9485078
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
16. The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.
Salem D; Subang R; Laplante P; Levine JS; Rauch J
Lupus; 2014 Oct; 23(12):1327-31. PubMed ID: 25228740
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I.
Manfredi AA; Rovere P; Heltai S; Galati G; Nebbia G; Tincani A; Balestrieri G; Sabbadini MG
Arthritis Rheum; 1998 Feb; 41(2):215-23. PubMed ID: 9485079
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
